Related Experiment Video
Updated: Oct 26, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
[New approval: Avelumab - maintenance therapy for advanced or metastatic urothelial carcinoma]
Iona Campo Le Brun1, Marc-Antoine Benderra2
1Groupe hospitalier Henri-Mondor, hôpitaux universitaires Henri-Mondor, 1, rue Gustave-Eiffel, 94000 Créteil, France.
No abstract available in PubMed .
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
Tumor Immunotherapy
Treatment Resistant Cancers
Urinary Tract Calculi III: Medical Management
Targeted Cancer Therapies
There are several types of targeted therapies against...
Urinary Tract Infection IV: Nursing Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention